Last reviewed · How we verify

NCT04898296: Ex-6-rate

Exploration of Possible Reasons for the Discrepancy Between Expectation and Indication of Subjective Perceived Exertions

Completed Last updated 25 October 2022
What this trial tests

trial testing Questionnaire, Interview in Coronary Disease in 16 participants. Completed in 14 August 2022.

Timeline
1 July 2021
Primary endpoint
14 August 2022
14 August 2022

Quick facts

Lead sponsorKlinik Barmelweid
StatusCompleted
Study typeOBSERVATIONAL
Enrollment16
Start date1 July 2021
Primary completion14 August 2022
Estimated completion14 August 2022
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Klinik Barmelweid

Who can join

Adults 55 to 90, any sex, with Coronary Disease or Exercise Test. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The 6-minute walk test is a test of physical performance in physiotherapy with lungs and heart patients (Pollentier 2010). However, only 8 and 11% of patients in everyday test situations report a score of 7 or higher on a scale of 0-10 for effort (Jehn 2009). This study is intended to explore, based on grounded theory, why the majority of patients do not assess themselves according to the almost maximum performance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. 6-Minute Walk Test: Exploring Factors Influencing Perceived Intensity in Older Patients Undergoing Cardiac Rehabilitation-A Qualitative Study.
    Büsching G, Schmid JP. · · 2025 · PMID 40218033 · DOI 10.3390/healthcare13070735

Verify or expand the search:

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04898296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing